Y-Intercept (HK)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13,662
| Closed | -$46.6K | – | 1294 |
|
2024
Q3 | $46.6K | Buy |
+13,662
| New | +$46.6K | ﹤0.01% | 1227 |
|
2024
Q1 | – | Sell |
-18,214
| Closed | -$185K | – | 1460 |
|
2023
Q4 | $185K | Buy |
+18,214
| New | +$185K | 0.02% | 1018 |
|
2023
Q3 | – | Sell |
-27,340
| Closed | -$225K | – | 1176 |
|
2023
Q2 | $225K | Buy |
+27,340
| New | +$225K | 0.02% | 888 |
|
2021
Q3 | – | Sell |
-4,877
| Closed | -$276K | – | 712 |
|
2021
Q2 | $276K | Sell |
4,877
-1,579
| -24% | -$89.4K | 0.07% | 432 |
|
2021
Q1 | $261K | Buy |
+6,456
| New | +$261K | 0.07% | 466 |
|